Q&A with FDA
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA. Perhaps you have had the same questions but never asked.
| Title | Date | Podcast | Transcript |
|---|---|---|---|
| CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito | July 24, 2023 |
Listen |
Transcript |
| FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | June 29, 2023 |
Listen |
Transcript |
| Drug Shortages with CDR Emily Thakur | May 17, 2023 |
Listen |
Transcript |
| Generics-at-a-Glance with Dr. Sarah Ibrahim | May 2, 2023 |
Listen |
Transcript |
| Expanded Access with Dr. Jacqueline Corrigan-Curay | March 13, 2023 |
Listen |
Transcript |
| MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan | February 1, 2023 |
Listen |
Transcript |
| FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska | October 25, 2022 |
Listen |
Transcript |
| Clinical Trial Basics with Dr. Robert Temple | September 28, 2022 |
Listen |
Transcript |
| Conversation on Paxlovid with Dr. John Farley | July 20, 2022 | Listen Run Time: 00:14:46 |
Transcript |